This article discusses the updated recommendations for use of inhaled medications in patients with chronic obstructive pulmonary disease, effective 1 August 2018.
Written by Dr Philip Lee BScMed MBBS (Hons) UNSW FRACP
Dr Philip Lee is a consultant in Respiratory and Sleep Medicine at St George Hospital. He has received local and international awards for his research work with continuing clinical and research interests in COPD, respiratory failure, non-invasive ventilation and sleep medicine. He is an expert advisor for Research Review Australia in COPD and has been an invited speaker at various local meetings. In 2016, Dr Lee received the St George Individual Volunteer Achievement Award for his outstanding contribution to the community.